Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Warren

Showing results (671-680 of 910) with videos related to

Pageof 91
Sort By:
Dermatology and Therapy|October 6, 2023
Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-AnalysisApril W Armstrong, Richard B Warren, Yichen Zhong, et al.
Journal of Clinical Laboratory Analysis|January 1, 1994
Genotype-phenotype pitfalls in Gaucher diseaseP M Strasberg, B L Triggs-Raine, I B Warren, et al.
The British Journal of Dermatology|April 4, 2023
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)Duc Binh Phan, Anthony P Bewley, Catherine H Smith, et al.
The British Journal of Dermatology|May 13, 2021
Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory diseaseA Al-Janabi, Z Littlewood, C E M Griffiths, et al.
American Journal of Medical Genetics. Part A|August 13, 2019
Longitudinal MRI findings in patient with SLC25A12 pathogenic variants inform disease progression and classificationBrian C Kavanaugh, Emily B Warren, Ozan Baytas, et al.
Genes and Immunity|January 22, 2004
Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitisM J Carter, S Jones, N J Camp, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
Molecular Carcinogenesis|January 1, 1993
Association of protein kinase C activation with induction of ornithine decarboxylase in murine but not human keratinocyte culturesS M Fischer, M L Lee, R E Maldve, et al.
The British Journal of Dermatology|April 4, 2017
Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasisI Y K Iskandar, D M Ashcroft, R B Warren, et al.
The British Journal of Dermatology|November 20, 2008
Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphismsR B Warren, R L Smith, E Campalani, et al.
Pageof 91

Showing results (671-680 of 910) with videos related to

Sort By:
Pageof 91
Dermatology and Therapy|October 6, 2023
Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-AnalysisApril W Armstrong, Richard B Warren, Yichen Zhong, et al.
Journal of Clinical Laboratory Analysis|January 1, 1994
Genotype-phenotype pitfalls in Gaucher diseaseP M Strasberg, B L Triggs-Raine, I B Warren, et al.
The British Journal of Dermatology|April 4, 2023
Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)Duc Binh Phan, Anthony P Bewley, Catherine H Smith, et al.
The British Journal of Dermatology|May 13, 2021
Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory diseaseA Al-Janabi, Z Littlewood, C E M Griffiths, et al.
American Journal of Medical Genetics. Part A|August 13, 2019
Longitudinal MRI findings in patient with SLC25A12 pathogenic variants inform disease progression and classificationBrian C Kavanaugh, Emily B Warren, Ozan Baytas, et al.
Genes and Immunity|January 22, 2004
Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitisM J Carter, S Jones, N J Camp, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
Molecular Carcinogenesis|January 1, 1993
Association of protein kinase C activation with induction of ornithine decarboxylase in murine but not human keratinocyte culturesS M Fischer, M L Lee, R E Maldve, et al.
The British Journal of Dermatology|April 4, 2017
Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasisI Y K Iskandar, D M Ashcroft, R B Warren, et al.
The British Journal of Dermatology|November 20, 2008
Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphismsR B Warren, R L Smith, E Campalani, et al.
Pageof 91